What, How, and How Much Should Patients with Burns be Fed?

被引：47
作者：
Williams, Felicia N. [1 ,2 ]
Branski, Ludwik K. [1 ,2 ]
Jeschke, Marc G. [3 ,4 ]
Herndon, David N. [1 ,2 ]
机构：
[1] Shriners Hosp Children, Dept Surg, Galveston, TX 77550 USA
[2] Univ Texas Med Branch, Galveston, TX 77550 USA
[3] Sunnybrook Hlth Sci Ctr, Ross Tilley Burn Ctr, Toronto, ON M4N 3M5, Canada
[4] Univ Toronto, Dept Surg, Div Plast Surg, Toronto, ON M4N 3M5, Canada
来源：
SURGICAL CLINICS OF NORTH AMERICA | 2011年 / 91卷 / 03期
关键词：
Hypermetabolic response; Burn injury; Trauma; Nutrition; HUMAN GROWTH-HORMONE; RANDOMIZED CONTROLLED-TRIAL; INSULIN-TREATMENT IMPROVES; DOUBLE-BLIND TRIAL; ENERGY-EXPENDITURE; FACTOR-I; GLUCOSE-METABOLISM; MUSCLE PROTEIN; BETA-BLOCKADE; HYPERMETABOLIC RESPONSE;
D O I：
10.1016/j.suc.2011.03.002
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The hypermetabolic response to severe burn injury is characterized by hyperdynamic circulation and profound metabolic, physiologic, catabolic, and immune system derangements. Failure to satisfy overwhelming energy and protein requirements after, and during, severe burn injury results in multiorgan dysfunction, increased susceptibility to infection, and death. Attenuation of the hypermetabolic response by various pharmacologic modalities is emerging as an essential component of the management of patients with severe burn injury. This review focuses on the more recent advances in therapeutic strategies to attenuate the hypermetabolic response and its postburn-associated insulin resistance.
引用
收藏
页码：609 / +
页数：22
相关论文
共 202 条
  • [1] Insulin therapy in burn patients does not contribute to hepatic triglyceride production
    Aarsland, A
    Chinkes, DL
    Sakurai, Y
    Nguyen, TT
    Herndon, DN
    Wolfe, RR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (10) : 2233 - 2239
  • [2] Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone - Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged
    Aarsland, A
    Chinkes, D
    Wolfe, RR
    Barrow, RE
    Nelson, SO
    Pierre, E
    Herndon, DN
    [J]. ANNALS OF SURGERY, 1996, 223 (06) : 777 - 787
  • [3] Elevated circulating leukemia inhibitory factor in patients with extensive burns
    Akita, S
    Akino, K
    Ren, SG
    Melmed, S
    Imaizumi, T
    Hirano, A
    [J]. JOURNAL OF BURN CARE & RESEARCH, 2006, 27 (02) : 221 - 225
  • [4] THE IMPORTANCE OF LIPID TYPE IN THE DIET AFTER BURN INJURY
    ALEXANDER, JW
    SAITO, H
    TROCKI, O
    OGLE, CK
    [J]. ANNALS OF SURGERY, 1986, 204 (01) : 1 - 8
  • [5] [Anonymous], TOTAL BURN CARE
  • [6] ARORA NS, 1982, AM REV RESPIR DIS, V126, P5
  • [7] RESPIRATORY CHANGES INDUCED BY THE LARGE GLUCOSE LOADS OF TOTAL PARENTERAL-NUTRITION
    ASKANAZI, J
    ROSENBAUM, SH
    HYMAN, AI
    SILVERBERG, PA
    MILICEMILI, J
    KINNEY, JM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (14): : 1444 - 1447
  • [8] Drug therapy - Metformin
    Bailey, CJ
    Turner, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) : 574 - 579
  • [9] STIMULATION OF MUSCLE PROTEIN-DEGRADATION AND PROSTAGLANDIN-E2 RELEASE BY LEUKOCYTIC PYROGEN (INTERLEUKIN-1) - A MECHANISM FOR THE INCREASED DEGRADATION OF MUSCLE PROTEINS DURING FEVER
    BARACOS, V
    RODEMANN, HP
    DINARELLO, CA
    GOLDBERG, AL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (10) : 553 - 558
  • [10] Baron P. W., 1997, Journal of Burn Care and Rehabilitation, V18, P223, DOI 10.1097/00004630-199705000-00008
12345678910